From Emily Humpal <[email protected]>
Subject Stop funneling more money toward failing Affordable Care Act
Date July 26, 2022 6:59 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])
[link removed]
Stop funneling more money toward failing Affordable Care Act

Detroit News | Sally Pipes
July 20, 2022

Democrats in Congress are scrambling to extend ([link removed]) the enhanced Obamacare subsidies signed into law by President Biden last year as part of the American Rescue Plan Act.

It’s no mystery why. If lawmakers allow these premium tax credits to expire — as they’re set to at the end of this year — millions of Americans will see the cost of coverage on Obamacare’s exchanges surge.

Read more. . . ([link removed])

Congress: To prevent addiction, empower physicians and patients to choose non-opioids

The Hill | Henry Miller
July 18, 2022

Every month, it seems, the United States smashes another unenviable record when it comes to drug addiction and overdose statistics. According to the Centers for Disease Control and Prevention (CDC), the latest data show a jaw-dropping 108,000 overdose deaths ([link removed]) in 2021. America’s families and communities are reeling — and the federal government needs to help.

Read more . . . ([link removed])

Drug Price Controls Are Not the Solution to Another Bad Inflation Report

Right by the Bay | Wayne Winegarden
July 19, 2022

The July 13^th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious.

Read more. . . ([link removed])

It's Time To Cure The FDA's Regulatory Sclerosis

Forbes | Sally Pipes
July 18, 2022

Late last month, the Food and Drug Administration advised ([link removed]) COVID-19 vaccine manufacturers to develop booster shots aimed at the omicron variant of the virus. Regulators hope the shots will be ready by the fall ([link removed]) .

That will probably be too late to stop BA.5, the highly transmissible subvariant that has quickly become the dominant strain ([link removed]) in the United States.

Read more. . . ([link removed])
We've been nominated - and we need YOUR help to win!

PRI’s team is a Communications Excellence Award nominee for receiving a “bold brand boost” from two major items in our policy agenda – The Homeschool Boom & The CEQA Gauntlet.

Click on the image below to cast your vote and help PRI bring the trophy home!
[link removed]

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2022 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 | Pasadena, CA 91116

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis